Association of natural killer cell depletion with induction of mixed chimerism and allograft tolerance in non-human primates

Transplantation

Volumn 70, Issue 2, 2000, Pages 368-374

  Kawai, Tatsuo ^a   Wee, Siew Lin ^a   Bazin, Herve ^b   Latinne, Dominique ^b   Phelan, Joanne ^a   Boskovic, Svetlan ^a   Ko, Dicken S C ^a   Hong, Han Zhou ^a   Mauiyyedi, Shamila ^a   Nadazdin, Ognjenka ^a   Abrahamian, Gregory ^a   Preffer, Frederic ^a   Colvin, Robert B ^a   Sachs, David H ^b   Cosimi, A Benedict ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Massachusetts General Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; MONOCLONAL ANTIBODY; THYMOCYTE ANTIBODY;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHIMERA; CONTROLLED STUDY; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; KIDNEY TRANSPLANTATION; MALE; MONKEY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLENECTOMY; T LYMPHOCYTE; WHOLE BODY RADIATION;

EID: 0343193122     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200007270-00023     Document Type: Article

References (36)

1. Wood ML, Monaco AP.The effect of timing of skin grafts survival in ALS treated marrow infused mice. Transplantation 1977; 23: 78.
2. Thomas JM, Carver FM, Cunningham PRG, Olson LC, Thomas FT. Kidney allograft tolerance in primates without chronic immunosuppression-the role of veto cells. Transplantation 1991; 51: 198.
3. Thomas JM, Carver FM, Kasten-Jolly J, et al. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 1994; 57: 101.
4. Fontes P, Rao AS, Demetris AJ et al.Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart and pancreas islet transplantation. Lancet 1994; 2: 151.
5. Shapiro R, Rao AS, Fontes P, et al. Combined simultaneous kidney/bone marrow transplantation. Transplantation 1995; 60: 1421.
6. Rolles K, Burroughs AK, Davidson BR, et.al. Donor-specific bone marrow infusion after orthotopic liver transplantation. Lancet 1994; 2: 263.
7. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307 (5947): 168.
8. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989; 169: 493.
9. Tomita Y, Khan A, Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a non-myeloablative regimen. J Immunol 1994; 153: 1087.
10. Murphy JM, Kumar V, Bennet M. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized. J Exp Med 1987; 166: 1499.
11. Yankelevich B, Knobloch C, Nowicki M, Dennert G. A novel cell type responsible for marrow graft rejection in mice. T cells with NK phenotype cause acute rejection of marrow grafts. J Immunol 1989; 142: 3423.
12. Murphy WJ, Kumar V, Cope JC, Bennett M. An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells. J Immunol 1990; 144: 3305.
13. Takeda K, Moore MW, Dennert G. Acute rejection of marrow grafts in mice. Dependence on and independence of functional TCR in the rejection process. J Immunol 1994; 152: 4407.
14. Kawai T, Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995; 59: 256.
15. Kimikawa M, Sachs DH, Colvin RB, Bartholomew A, Kawai T, Cosimi AB. Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys. Transplantation 1997; 64: 709.
16. Kawai T, Poncelet A, Sachs DH, et al. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation 1999; 68: 1767.
17. Cosimi AB, Delmonico FL, Wright JK, et al. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery 1990; 108: 406.
18. Liang K-Y. Generalized estimating equations. In: Diggle PJ, Liang KY, Zeger SL, eds., Analysis of longitudinal data. Oxford: Clarendon Press, 1994; 142.
19. Yokoyama W. Natural killer cells. In: Paul WE, ed. Fundamental immunology, 4th ed. Philadelphia: Lippincott-Raven, 1999; 575.
20. Lanier LL. NK cell receptors. Annu Rev Immunol 1998; 16: 359.
21. Dorshkind K, Pollack SB, Bosma MJ, Phillips RA. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (SCID). J Immunol 1998; 134: 3798.
22. Murphy JW, Kumar V, Bennett M. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med 1987; 165: 1212.
23. Fisher A, Landais P, Friedrich W. et al. European experience of bone marrow transplantation for severe combined immunodeficiency. Lancet 1990; 2: 850.
24. Leeuwen JEMV, Tol MJDV, Schellekens PTA et al. Relationship between patterns of engraftment in peripheral blood and immune reconstitution for (severe) combined immunodeficiency. Blood 1994; 84: 3936.
25. Kaufman CL, Colson YL, Wren SM, Watkins S, Simmons RL, Ildstad ST. Phenotypic characterization of a novel bone marrow-derived cell that facilitate engraftment of allogeneic bone marrow stem cells. Blood 1994; 84: 2436.
26. Martin PJ. Prevention of allogeneic marrow graftrejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism. Blood 1996; 88: 962.
27. Yamada YK, Yabe M, Tatsumi M. Phenotypic characterization of cynomolgus monkey natural killer cells. Cell Immunol 1989; 122: 524.
28. Malyguine AM, Saadi S, Platt JL, Dawson JR. Differential expression of natural killer cell markers: Human versus Baboon. Transplantation 1996; 62: 1319.
29. Rits J, Schmidt RE, Michon J, et al. Characterization of functional surface structures on human natural killer cells. Adv Immunol 42:181-211.
30. Rolstad B, Fossum S, Bazin H, et al. The rapid rejection of allogeneic lymphocytes by a non-adaptive, cell-mediated mechanism (NK activity). Immunology 1985; 54: 127.
31. McNeilage LJ, Heslop BF. Lymphocyte homing in syngeneic and unsensitized MHC compatible allogeneic host. I. Evidence for both syngeneic self-recognition and early killing of allogeneic cells. Cell Immunol 1980; 50: 58.
32. Cosimi AB. Antilymphocyte globulin - a final (?) look. In: Morris PJ, Tilney NL, eds. Progress in transplantation, vol. 2. Edinburgh: Churchhill Livingston, 1986; 167.
33. Malilay GP, Sevenich EA, Condie RM, Filipovich AH. Prevention of graft rejection in allogeneic bone marrow transplantation: I. Preclinical studies with antithymocyte globulins. Bone Marrow Transplant 1989; 4: 107.
34. Barber WH, Mankin JA, Laskow DA, et al. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991; 51: 70.
35. Markus PM, Brink VD, Luchs BA, et al. Effects of in vivo treatment with FK506 on natural killer cells in rats. Transplantation 1991; 51: 913.
36. Wasik M, Gorski A, Stepien-Sopniewska B, Lagodzinski Z, et.al. Effects of FK506 versus cyclosporine on human natural and antibody-dependent cytotoxicity reactions in vitro. Transplantation 1991; 51: 268.